Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases.
Animal models are powerful tools to analyze the mechanism of the induction of human breast cancer. Here we report a detailed analysis of mammary tumor progression in one mouse model of breast cancer caused by expression of the polyoma middle T oncoprotein (PyMT) in the mammary epithelium, and its comparison to human breast tumors. In PyMT mice, four distinctly identifiable stages of tumor progression from premalignant to malignant stages occur in a single primary tumor focus and this malignant transition is followed by a high frequency of distant metastasis. These stages are comparable to human breast diseases classified as benign or in situ proliferative lesions to invasive carcinomas. In addition to the morphological similarities with human breast cancer, the expression of biomarkers in PyMT-induced tumors is also consistent with those associated with poor outcome in humans. These include a loss of estrogen and progesterone receptors as well as integrin-beta1 expression and the persistent expression of ErbB2/Neu and cyclinD1 in PyMT-induced tumors as they progress to the malignant stage. An increased leukocytic infiltration was also closely associated with the malignant transition. This study demonstrates that the PyMT mouse model is an excellent one to understand the biology of tumor progression in humans.
Lin
Elaine Y
EY
Center for Study of Reproductive Biology and Women's Health, Departments of Developmental and Molecular Biology/Obstetrics and Gynecology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA.
Jones
Joan G
JG
Li
Ping
P
Zhu
Liyin
L
Whitney
Kathleen D
KD
Muller
William J
WJ
Pollard
Jeffrey W
JW
D000818:Animals; D000957:Antigens, Viral, Tumor; D015153:Blotting, Western; D002471:Cell Transformation, Neoplastic / Q000473:pathology*; D004195:Disease Models, Animal; D018450:Disease Progression; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008325:Mammary Neoplasms, Experimental / Q000378:metabolism* / Q000473:pathology* / Q000821:virology; D051379:Mice; D008822:Mice, Transgenic; D015513:Oncogene Proteins / Q000096:biosynthesis; D011120:Polyomavirus / Q000276:immunology; D011230:Precancerous Conditions / Q000378:metabolism / Q000473:pathology; D011960:Receptors, Estrogen / Q000378:metabolism; D011980:Receptors, Progesterone / Q000378:metabolism; D014412:Tumor Virus Infections / Q000276:immunology
D000957:Antigens, Viral, Tumor; D015513:Oncogene Proteins; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone